CompletedPhase 2NCT03046381
Tocilizumab in Patients With Schnitzler's Syndrome
Studying Schnitzler syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Karoline Krause
- Principal Investigator
- Karoline Krause, MDCharite University, Berlin, Germany
- Intervention
- Tocilizumab(drug)
- Enrollment
- 8 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2017 – 2019
Study locations (1)
- Charité - Universitätsmedizin Berlin, Dpt. of Dermatology and Allergy, Berlin, Germay, Germany
Collaborators
Roche Pharma AG
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03046381 on ClinicalTrials.gov